(Q44003735)

28 November 2017

Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction (English)

1 reference

28 November 2017

Richard J Hawksworth

1

1 reference

28 November 2017

Andrew P Sykes

2

1 reference

28 November 2017

Melissa Faris

3

1 reference

28 November 2017

Tim Mant

4

1 reference

28 November 2017

Tak H Lee

5

1 reference

28 November 2017

1 May 2002

1 reference

Annals of Allergy, Asthma & Immunology

28 November 2017

1 reference

28 November 2017

88

1 reference

28 November 2017

5

1 reference

28 November 2017

473-477

1 reference

Stratospheric sink for chlorofluoromethanes: chlorine atom-catalysed destruction of ozone

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Safety of propellants.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

A standardized method of evaluating exercise-induced asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

The effect of exercise on ventilatory function in the child with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Exercise asthma and disodium cromoglycate.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Prevention of exercise-induced asthma by drugs inhaled from metered aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Beta-adrenergic drugs in the management of asthma in athletes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

GR106642X: a new, non-ozone depleting propellant for inhalers.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Continuing patient care with metered-dose inhalers.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Clinical comparability of ventolin formulated with hydrofluoroalkane or conventional chlorofluorocarbon propellants in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

Pharmaceutical transition to non-CFC pressurized metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962385-X

7 January 2021

10.1016/S1081-1206(10)62385-X

Identifiers

DOI

1 reference

28 November 2017

1 reference